Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FAKPQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,516
Award facts
- Contract value 100% obligated
- $30,515.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $30,515.78 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick (an injectable medication for cholesterol management) on January 22, 2026, with an ultimate completion date of January 23, 2026. This non-set-aside contract represents a firm fixed-price delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider serving federal government agencies.
This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical supply relationship with the Defense Logistics Agency, which encompasses an IDC valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., holds a larger IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen competes on a full and open basis for federal contracts and supplies a diverse array of medications and medical commodities across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FAKPQ?
SPE2DR26FAKPQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FAKPQ worth?
The government has obligated $30,516 on SPE2DR26FAKPQ.
Is contract SPE2DR26FAKPQ an order under another contract?
Yes. SPE2DR26FAKPQ is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKPQ competed?
The extent of competition for SPE2DR26FAKPQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award